Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elrexfio
Pharma
Elrexfio ph. 3 win tees up label expansion in multiple myeloma
Pfizer's Elrexfio decreased risk of disease progression and death in RRMM patients whose disease worsened after frontline options.
Donavyn Coffey
Oct 27, 2026 11:15am
Pfizer looks to jump start Elrexfio with topline win
Apr 29, 2026 10:16am
Pfizer sees 8 blockbuster cancer drugs from each focus area
Jun 13, 2024 12:45pm
Pfizer brings multiple myeloma battle to J&J with new FDA nod
Aug 14, 2023 2:28pm
